RXRX Today - Jul 11: Insider Selling Spooks Investors
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
So, what happened? RXRX got smoked today, and it wasn't just a little dip. The stock slid after some insider selling news hit the wires. Blake Borgeson, a director at Recursion, dumped 40,000 shares for about $158,500. Yeah, that one stung. When insiders sell, it usually raises eyebrows, and today was no different. Investors hit that sell button fast, sending the stock down.
Now, let’s chat about the why. There’s been a lot of chatter lately about Recursion’s potential in the biotech and AI space. Just yesterday, there were some positive vibes with the stock soaring pre-market after they reported beating earnings in Q4. The CEO even said they reached an “inflection point,” which sounds super promising, right? But then, bam, this insider selling pops up, and people start to panic. It’s like, one step forward, two steps back.
Also, on top of all that, there’s been buzz about RXRX being seen as one of those penny stocks that some big names are keeping an eye on. But with this selling news, it feels like that hype took a hit. So, you’ve got this mix of potential and caution swirling around.
One thing to keep in mind is that the volume today was pretty high, but it was still below the average. So, a lot of folks were watching, but maybe not as many were buying. Just something to think about.
Alright, that's the scoop on Recursion today. Stocks can be wild and unpredictable, and this one’s no exception. Just remember, I’m here to keep you informed and entertained, not to give financial advice. Take care, and catch you later!
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません